Project Grant R21EB038618
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $471,967 on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award funds development of dual density-dependent molecular AND gates—engineered targeting ligands that selectively bind cells expressing high levels of two distinct antigens via bispecific avidity. The research addresses on-target,...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $209,940 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a portable phase-only parallel transmission interface for enhancing phosphorus-31 magnetic resonance spectroscopy imaging at 7 Tesla. The recipient will design and build a digital-controlled, RF broadband interface that adjusts...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,364,828 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to conduct research on safe, effective, and trustworthy artificial intelligence deployment across U.S. healthcare delivery organizations. The project uses mixed methods to identify barriers to and mitigation strategies for AI capability...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,073,800 on April 10, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop advanced radiofrequency and gradient technologies for whole-brain functional and structural connectivity mapping at 10.5T MRI. The work addresses suboptimal RF and gradient technologies that limit the 10.5T scanner's capability...
- The National Institute of General Medical Sciences awarded the Regents of the University of Minnesota $200,484 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop an interoperable artificial intelligence early warning system for unrecognized in-hospital patient deterioration. The award funds transformation of the Acute Clinical Deterioration Calculator (ACDC), a machine learning model that predicts deterioration 3.4 hours earlier than...
- The National Institute of General Medical Sciences awarded the Regents of the University of Minnesota $398,144 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to engineer immunocompetent tissue models for studying inflammatory disease mechanisms. The research combines human pluripotent stem cells and genetic engineering to create microtissues containing tissue-resident macrophages with controllable inflammatory states. The project targets skeletal...
- The Regents of the University of Minnesota received a $599,994.30 Project Grant award from the National Institutes of Health National Institute of Biomedical Imaging and Bioengineering to develop novel radiofrequency hardware for use at 10.5 Tesla to obtain functional magnetic resonance imaging signals at ultra-high resolutions in non-human primates. The goal is to directly test how well whole brain directional connectivity estimates from fMRI correspond with ground truth tract tracing...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded $366,517 to the Regents of the University of Minnesota on August 6, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The award funds investigation of myosin-based mechanisms in filopodia formation. The research examines how filopodia—dynamic, actin-rich cellular projections that enable cell navigation, intercellular contact...
- The National Institute of General Medical Sciences awarded the Regents of the University of Minnesota $404,165 on July 23, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to advance cryoimaging techniques for visualizing cellular communication mechanisms. The research applies in situ correlative cryoimaging to decode the molecular architecture of juxtacrine signaling, using the Notch pathway as a primary model system. The work aims to directly image Notch-ligand...
- The National Institute of General Medical Sciences awarded Regents of the University of Minnesota $373,737 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct research on the dynamics of motile flagella in fluid media. The recipient will develop new physical model systems and advanced imaging techniques to elucidate fluid-mediated flagellar dynamics in two critical research areas: resolving the synchronized dynamics of prokaryotic flagella...
The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $220,588 on August 25, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award funds a three-year project to develop methodology for identifying motor phenotypes in a normative population using multimodal sensing and deep learning-based clustering. The research will collect kinematic and inertial measurement data from 400 individuals spanning ages 5 to 85 and older while participants perform prescribed reaching movements and functional tasks including pouring and drinking. The team will use deep representation networks to encode motion in latent space and apply clustering optimization to determine movement phenotypes, with the long-term goal of inferring a patient's movement phenotype from clinical recordings using limited equipment and time. The project addresses limitations in traditional clinical motor assessments by applying kinematic analysis to detect subtle impairments and compensatory movement strategies that can guide targeted interventions. Performance occurs in Minneapolis, Minnesota. The period of performance runs through May 31, 2029. The award is classified as a Project Grant, a standard assistance type under NIBIB's portfolio of hypothesis- and technology-driven research supporting biomedical imaging and bioengineering discovery and application.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $220.6k | 8/21/26 |